US Generic Injectables Market Analysis & Forecast To 2022 - ResearchAndMarkets.com

DUBLIN--()--The "US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to ResearchAndMarkets.com's offering.

The US generic injectables market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016. The market growth can be attributed to the low cost of these drugs as compared to their branded counterparts.

Over the next few years, the market is expected to be driven by a number of favourable factors. The cases of chronic diseases have been increasing on account of ageing population, sedentary lifestyles and poor eating habits. This has resulted in a heightened demand for generic injectables. Furthermore, the drug shortages in the country coupled with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Additionally, the patent expiry of a large number of branded injectable drugs is expected to support the market growth.

The report has segmented the market on the basis of therapeutic area and covers oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular diseases, etc. Among these, oncology generic injectables represent the largest segment. The report has further analysed the various containers used for generic injectables including vials, premix, prefilled syringes and ampoules. On the basis of distribution channels, the report finds that hospitals dominate the market, accounting for the majority of the share.

Companies Mentioned

  • App
  • Henry Shein Inc.
  • Hikma
  • Hospira
  • Sagent
  • Sandoz

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Generic Drug Industry

6 US Generic Drug Industry

7 US Generic Drug Industry - Drug Delivery Systems

8 Global Generic Injectables Industry

9 US Generic Injectables Industry

10 Market by Therapeutic Area

11 Market by Containers

12 Market by Distribution Channel

13 US Generic Injectable Market: Competitive Landscape

14 Generic Injectables Manufacturing Process

15 Project Details, Requirements and Costs Involved

16 Key Players Profiles

For more information about this report visit https://www.researchandmarkets.com/research/f8tkzd/us_generic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables